Now playing BioAge Labs wants to raise $200 million in IPO to develop obesity and diabetes drugsPublishedSeptember 25, 2024
Now playing Nvidia stock's 20% drop is actually a good sign for the market, strategist says. Here's whyByAndy MillsPublishedSeptember 24, 2024
Now playing Nvidia stock's 20% drop is actually a good sign for the market, strategist says. Here's whyPublishedSeptember 24, 2024
Now playing Uber delivery partnership sends Darden Restaurants stock cruising higherPublishedSeptember 19, 2024
Now playing OpenAI's Safety and Security Committee is going independent and they have some suggestionsPublishedSeptember 18, 2024
Get ready for stocks to soar when the Fed cuts interest rates, strategist saysByAndy MillsPublishedSeptember 17, 2024
Now playing Nvidia isn't the top stock anymore. A strategist says buy this insteadPublishedSeptember 17, 2024
Now playing The Fed will go for a bigger interest rate cut — and stocks will soar, strategist saysPublishedSeptember 17, 2024
Now playing From Nvidia to Apple, tech stocks could get a boost from Fed rate cuts, analysts sayPublishedSeptember 16, 2024
Now playing Ozempic maker Novo Nordisk has an experimental anti-obesity pill with noteworthy early trial resultsPublishedSeptember 11, 2024
Now playing Consumer spending trends are split and Walmart is seeing the upsidePublishedSeptember 11, 2024
Apple spent big on AI — and it's paying off with the iPhone 16, analyst saysByAndy MillsPublishedSeptember 10, 2024
Now playing Apple spent big on AI and with iPhone 16 it's paying off, analyst saysPublishedSeptember 10, 2024
Now playing Nvidia stock is navigating one of its most turbulent weeks everPublishedSeptember 5, 2024
Now playing Most Americans do not feel rich with a million dollars, survey findsPublishedSeptember 4, 2024
Big Tech will go full speed ahead on AI spending after Nvidia's earnings, strategist saysByAndy MillsPublishedSeptember 4, 2024
